- This event has passed.
Early-Stage Collaborations: Strategies and Considerations
This presentation provides an overview of structuring research collaborations and licensing agreements in life sciences, covering the strategic and contractual processes for selecting and nominating research targets, defining “Licensed Compound” with attention to intellectual property, development stage, and collaboration scope, and addressing the complexities of drafting bespoke agreements, including governance, license grant scope, committee structures, exclusivity/non-compete terms, and diligence obligations. It also examines recent trends in artificial intelligence collaborations, detailing considerations for data rights, compound IP ownership, AI platform access, improvements, and risk allocation in AI-driven drug discovery partnerships.
Hosted by:
